UFPT Investor News

UFP Technologies announced that Chairman & CEO R. Jeffrey Bailly and Chief Financial Officer Ron Lataille will participate at the Southwest IDEAS Investor Conference on November 16, 2022. UFP Technologies’ presentation is scheduled to begin at 3:00 pm CT on November 16. The presentation will be webcast and can be accessed through the conference site, www.IDEASconferences.com, and in the investor relations section of the company's website: www.UFPT.com/Investors.

Newburyport, Mass., November 2, 2022. UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today reported net income of $19.5 million or $2.56 per diluted common share outstanding for its third quarter ended September 30, 2022, compared to net income of $3.8 million or $0.50 per diluted common share outstanding for the same quarter in 2021.

UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today reported net income of $8.9 million or $1.17 per diluted common share outstanding for its second quarter ended June 30, 2022, compared to net income of $4.7 million or $0.62 per diluted common share outstanding for the same quarter in 2021.

UFP Technologies today announced the sale of its molded fiber business and related real estate in Iowa to CKF, Inc. for approximately $32 million.

UFP Technologies announced the opening of a new medical manufacturing operation in Tijuana, Mexico. The 84,000-square-foot, FDA-registered facility will feature clean room and clean space medical device manufacturing and assembly.

UFP Technologies announced R. Jeffrey Bailly, Chairman and Chief Executive Officer and Ron Lataille, Chief Financial Officer will participate in the virtual East Coast IDEAS Investor Conference on June 22 and 23, 2022.  UFP Technologies, Inc.’s presentation is scheduled to be available at 6:00 am ET on June 22 and will be accessible through the conference site. The presentation will also be webcast and can be accessed through the conference website, the host’s main website: www.IDEASconferences.com, and in the investor relations section of the company's website: www.UFPT.com/Investors.

UFP Technologies today reported net income of $4.9 million or $0.64 per diluted common share outstanding for its first quarter ended March 31, 2022, compared to net income of $4.2 million or $0.55 per diluted common share outstanding for the same quarter in 2021. Sales for the first quarter were $71.2 million compared to 2021 first quarter sales of $48.6 million.

UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced the acquisition of Advant Medical Ltd.  Founded in 1993 and headquartered in Galway, Ireland, with operations in Costa Rica and Mexico, Advant Medical is a developer and manufacturer of Class I, II, and III medical devices and packaging.   

UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today reported net income of $15.9 million or $2.09 per diluted common share outstanding for its year ended December 31, 2021, compared to net income of $13.4 million or $1.77 per diluted common share outstanding for 2020. Sales for 2021 were $206.3 million compared to 2020 sales of $179.4 million.

UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced the acquisition of DAS Medical, Inc. Founded in 2010 and headquartered in Atlanta, Georgia, with manufacturing in the Dominican Republic, DAS is a medical device contract manufacturer specializing in the design, development and production of single-use surgical equipment covers, robotic draping systems and fluid control pouches.

UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today reported net income of $3.8 million or $0.50 per diluted common share outstanding for its third quarter ended September 30, 2021, compared to net income of $3.0 million or $0.40 per diluted common share outstanding for the same quarter in 2020. Sales for the third quarter were $50.7 million compared to 2020 third quarter sales of $43.3 million. Net income for the nine-month period ended September 30, 2021 was $12.7 million or $1.67 per diluted common share outstanding compared to $9.2 million or $1.22 per diluted common share outstanding for the same period in 2020. Sales for the nine-month period ended September 30, 2021 were $150.0 million compared to sales of $134.2 million for the same period in 2020.

UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced the acquisition of Contech Medical, Inc. Founded in 1987 and headquartered in Providence, Rhode Island, with partner manufacturing in Costa Rica, Contech Medical is a global leader in the design, development, and manufacture of class III medical device packaging primarily for catheters and guidewires. Annual sales are approximately $18 million.

UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom converter of foams, plastics, and natural fiber materials primarily for the medical market, today announced that R. Jeffrey Bailly, Chairman and Chief Executive Officer, and Ron Lataille, Chief Financial Officer, will present and host one-on-one meetings with investors at the Sidoti Fall Virtual Investor Conference, taking place on September 22-23, 2021.

UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today reported net income of $4.7 million or $0.62 per diluted common share outstanding for its second quarter ended June 30, 2021, compared to net income of $2.3 million or $0.31 per diluted common share outstanding for the same quarter in 2020. Sales for the second quarter were $50.7 million compared to 2020 second quarter sales of $42.6 million. Net income for the six-month period ended June 30, 2021 was $8.9 million or $1.17 per diluted common share outstanding compared to $6.2 million or $0.82 per diluted common share outstanding for the same period in 2020. Sales for the six-month period ended June 30, 2021 were $99.3 million compared to sales of $90.9 million for the same period in 2020.

UFP Technologies (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced that Jeff Bailly, Chief Executive Officer, and Ron Lataille, Chief Financial Officer, will be presenting virtually and hosting one-on-one meetings with investors during the virtual East Coast IDEAS Investor Conference on June 16, 2021. Investors interested in participating in the virtual conference or scheduling a meeting with the Company may reach out to Jeff Elliott with Three Part Advisors, LLC at 214-966-9014.

UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today reported net income of $4.2 million or $0.55 per diluted common share outstanding for its first quarter ended March 31, 2021, compared to net income of $3.9 million or $0.52 per diluted common share outstanding for the same quarter in 2020. Sales for the first quarter were $48.6 million compared to 2020 first quarter sales of $48.3 million.

UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom converter of foams, plastics, and natural fiber materials primarily for the medical market, today announced that R. Jeffrey Bailly, Chairman and Chief Executive Officer, and Ron Lataille, Chief Financial Officer, will participate in the virtual Sidoti Conference on March 24, 2021.

UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today reported net income of $13.4 million or $1.77 per diluted common share outstanding for its year ended December 31, 2020, compared to net income of $19.8 million or $2.63 per diluted common share outstanding for 2019. Sales for 2020 were $179.4 million compared to 2019 sales of $198.4 million.

UFP Technologies, Inc., an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced Jeff Bailly, Chairman & Chief Executive Officer, and Ron Lataille, Chief Financial Officer, will present at the virtual Southwest IDEAS Investor Conference on November 18, 2020. The Company’s presentation will be webcast and is scheduled to be available at 7:00 am CST on November 18th. Management will also be hosting one-on-one meetings with investors throughout the day. Investors interested in participating in the virtual conference or scheduling a meeting with the Company may reach out to Jeff Elliott with Three Part Advisors, LLC at 972-423-7070.

UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today reported net income of $3.0 million or $0.40 per diluted common share outstanding for its third quarter ended September 30, 2020, compared to net income of $5.6 million or $0.75 per diluted common share outstanding for the same period in 2019. Sales for the third quarter were $43.3 million compared to third quarter sales of $49.4 million in 2019. Net income for the nine-month period ended September 30, 2020 was $9.2 million or $1.22 per diluted common share outstanding compared to $14.0 million or $1.87 per diluted common share outstanding for the same period in 2019. Sales for the nine-month period ended September 30, 2020 were $134.2 million compared to sales of $148.1 million for the same period in 2019.

UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today reported net income of $2.3 million or $0.31 per diluted common share outstanding for its second quarter ended June 30, 2020, compared to net income of $4.6 million or $0.62 per diluted common share outstanding for the same period in 2019. Sales for the second quarter were $42.6 million compared to second quarter sales of $51.4 million in 2019. Net income for the six-month period ended June 30, 2020 was $6.2 million or $0.82 per diluted common share outstanding compared to $8.3 million or $1.11 per diluted common share outstanding for the same period in 2019. Sales for the six-month period ended June 30, 2020 were $90.9 million compared to sales of $98.7 million for the same period in 2019.

UFP Technologies (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced that Ron Lataille, Chief Financial Officer, will be hosting virtual one-on-one meetings with investors during the virtual East Coast IDEAS Investor Conference on June 23-24, 2020. Investors interested in participating in the virtual conference or scheduling a meeting with the Company may reach out to Jeff Elliott with Three Part Advisors, LLC at 972-423-7070.

UFP Technologies, Inc.  (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today reported net income of $3.9 million or $0.52 per diluted common share outstanding for its first quarter ended March 31, 2020, compared to net income of $3.7 million or $0.50 per diluted common share outstanding for the same quarter in 2019.  Sales for the first quarter were $48.3 million compared to 2019 first quarter sales of $47.3 million.  

UFP Technologies (UFPT), today announced that R. Jeffrey Bailly, Chairman & CEO, and Ron Lataille, Chief Financial Officer, will present at the Southwest IDEAS Investor Conference on Wednesday, November 20, 2019, at the Westin Dallas Downtown in Dallas-TX. UFPT’s presentation is scheduled to begin at 9:45am CT. The presentation will be webcast live and may be accessed at the conference website, www.IDEASConferences.com, or in the investor relations section of the company's website: http://www.ufpt.com.

UFP Technologies, Inc. (NASDAQ: UFPT), an innovative designer and custom converter of foams, plastics, and natural fiber materials primarily for the medical market, today announced that R. Jeffrey Bailly, Chairman & CEO, and Ron Lataille, SVP & CFO, will be presenting at the Midwest IDEAS Investor Conference on Wednesday, August 28, 2019, at the Gwen Hotel in Chicago, Illinois.

UFP Technologies, a designer and custom converter of foams, plastics and specialty materials, today announced the acquisition of Dielectrics, Inc. Founded in 1954 and based in Chicopee, Massachusetts, Dielectrics is a leader in the design, development, and manufacture of medical devices using thermoplastic materials. Sales in 2017 were approximately $43 million.

UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom converter of foams, plastics, composites, and natural fiber materials, announced today that it has elected Cynthia Feldmann to its Board of Directors; she will also serve as Chair of the Audit Committee and member of the Nominating Committee.

UFP Technologies, Inc. (Nasdaq: UFPT), a manufacturer of packaging and component products, announced today it has expanded its Board of Directors to eight members with the appointment of Dan Croteau.